|
Volumn 3, Issue 1, 2001, Pages 49-57
|
Expert consensus guidelines for the medication treatment of bipolar disorder: A new treatment tool
a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
AMFEBUTAMONE;
ANTIDEPRESSANT AGENT;
BENZODIAZEPINE;
CARBAMAZEPINE;
CHLORPROMAZINE;
ETIRACETAM;
GABAPENTIN;
LAMOTRIGINE;
LIOTHYRONINE;
LITHIUM;
MIRTAZAPINE;
NEFAZODONE;
NEUROLEPTIC AGENT;
OLANZAPINE;
OXCARBAZEPINE;
PLACEBO;
PREGABALIN;
QUETIAPINE;
RISPERIDONE;
SEROTONIN UPTAKE INHIBITOR;
THYROID HORMONE;
THYROXINE;
TIAGABINE;
TOPIRAMATE;
TRICYCLIC ANTIDEPRESSANT AGENT;
VALPROATE SEMISODIUM;
VENLAFAXINE;
ZONISAMIDE;
ARTICLE;
CLINICAL TRIAL;
COGNITIVE DEFECT;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DEPRESSION;
DISEASE SEVERITY;
ELECTROCONVULSIVE THERAPY;
HUMAN;
MANIA;
MANIC DEPRESSIVE PSYCHOSIS;
MEDICAL DECISION MAKING;
MEDICAL RESEARCH;
MONOTHERAPY;
NEPHROLITHIASIS;
NEUROPATHY;
PATIENT EDUCATION;
PRACTICE GUIDELINE;
PSYCHOPHARMACOTHERAPY;
RANDOMIZED CONTROLLED TRIAL;
RASH;
RATING SCALE;
|
EID: 0035063359
PISSN: 15270815
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (1)
|
References (71)
|